Abstract
Relapsing polychondritis is an autoimmune disease that primarily manifests as cartilaginous tissue destruction. However, the immune impairment may also involve noncartilaginous tissues such as kidneys, blood vessels, etc. The disease may occur as a primary disorder or in association with other diseases. The case of a female patient with concurrent manifestation of myelodysplastic syndrome—refractory anemia with excess blasts, and relapsing polychondritis, is presented. The diagnosis of relapsing polychondritis was established ten months after the diagnosis of myelodysplastic syndrome, when the criteria for the former were met. Total hearing loss and blindness developed soon thereafter.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Michet CJ. Relapsing polychondritis (2005) In: Koopman WJ, Moreland LW (eds) Arthritis and allied conditions, 15th edn. Lippincott Williams & Wilkins, Philadelphia. URL: http://www.gateway.ut.ovid.com/gw1/ovidweb.cgi. (Accessed: Sep 21, 2005)
McAdam LP, O’Hanlan MA, Bluestone R et al (1976) Relapsing polychondritis: a prospective study of 23 patients and a review of the literature. Medicine 55:193–215
Damiani JM, Levin HL (1979) Relapsing polychondritis—report of ten cases. Laryngoscope 89:929–946
Vάrkonyi J, Jakab L, Zalatnay A, Nagy P, Vάmos R, Szombathy T (1997) Polychondritis terminating in eosinophilic leukemia. Pathol Oncol Res 3:135–138
Banerjee SS, Morris DP, Rothera MP, Routledge RC (2001) Relapsing polychondritis associated with monoclonal gammopathy in a patient with myelodysplastic syndrome. J Laryngol Otol 115:482–484
Heo SW, Cho KH, Ryu JI, Chung SH, Kim CG, Kim SG, Choe JY (2003) A case of relapsing polychondritis associated with myelodysplastic syndrome with erythroid hypoplasia/aplasia. Kor J Int Med 18:251–254
Wright MJ, Bel’eed K, Sellars L, Richmond I (1997) Relapsing polychondritis and myelodysplasia. Nephrol Dial Transplant 12:1704–1707
Hebbar M, Brouillard M, Wattel E, Decoulx M, Hatron P-Y, Devulder B, Fenaux P (1995) Association of myelodysplastic syndrome and relapsing polychondritis: further evidence. Leukemia 9:731–733
Hall R, Hopkinson N, Hamblin T (2000) Relapsing polychondritis, smouldering non-secretory myeloma and early myelodysplastic syndrome in the same patient: three difficult diagnoses produce a life threatening illness. Leukemia Res 24:91–93
Michel CJ, McKenna CH, Luthra HS, O’Fallon WM (1986) Relapsing polychondritis: survival and predictive role of early disease manifestations. Ann Int Med 104:74–78
Van Besien K, Tricot G, Hoffman R (1992) Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndrome. Am J Hematol 40:47–50
Diebold J, Rauh G, Jager K, Löhrs U (1995) Bone marrow pathology in relapsing polychondritis: high frequency of myelodysplastic syndrome. Br J Haematol 9:820–830
Hamblin T (1992) Immunologic abnormalities in myelodysplastic syndromes. Hematol Oncol Clin North Am 6:571–586
Kent PD, Michet CJ, Luthra HS (2003) Relapsing polychondritis. Curr Opin Rheumatol 16:56–61
Buckner JH, Van Landeghen M, Kwok WW, Tsarknaridis L (2002) Identification of type II collagen peptide 261–273-specific T cell clones in a patient with relapsing polychondritis. Arthritis Rheum 46:238–244
Loeffler KU, McLean IW (2000) Bilateral necrotizing scleritis and blindness in the myelodysplastic syndrome presumably due to relapsing polychondritis. Acta Ophthalmol Scand 78:228–231
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coha, B., Fustar-Preradovic, L., Sekelj, S. et al. Total hearing loss and blindness caused by relapsing polychondritis and myelodysplastic syndrome. Eur Arch Otorhinolaryngol 264, 1517–1519 (2007). https://doi.org/10.1007/s00405-007-0387-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-007-0387-9